Outcomes of Intrauterine Device Insertion by Certified Midwives and Obstetric Nurse Practitioners.


Journal

Revista brasileira de enfermagem
ISSN: 1984-0446
Titre abrégé: Rev Bras Enferm
Pays: Brazil
ID NLM: 7910105

Informations de publication

Date de publication:
2023
Historique:
received: 26 06 2022
accepted: 04 05 2023
medline: 30 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

to evaluate the outcomes of Interval Copper Intrauterine Device (IUD) insertion performed by certified midwives and obstetric nurse practitioners at a Peri-Hospital Birth Center. a cross-sectional study was conducted involving 75 women who underwent IUD insertion between January 2018 and February 2020. Data collection was carried out using medical records and telephone interviews. no instances of uterine perforation were observed. Expulsion rates of the devices were 1.3% within 30 to 45 days of use and 5.3% within the first year of use. The follow-up removal rate was 4.0%. The average pain score reported was 4.2 (SD = 3.3). Among those who continued using the device, 93.1% expressed satisfaction. the findings demonstrate that IUD insertion by certified midwives and obstetric nurse practitioners is a safe procedure, yielding outcomes comparable to those reported in the existing literature.

Identifiants

pubmed: 38018608
pii: S0034-71672023000900210
doi: 10.1590/0034-7167-2022-0286
pmc: PMC10680391
pii:
doi:

Types de publication

Journal Article

Langues

eng por

Pagination

e20220286

Références

Rev Bras Enferm. 2020 Nov 11;73(suppl 4):e20200156
pubmed: 33206854
Obstet Gynecol. 2014 Mar;123(3):585-592
pubmed: 24499755
Int J Gynaecol Obstet. 2018 Sep;143 Suppl 1:20-27
pubmed: 30225873
Int J Gynaecol Obstet. 2018 Sep;143 Suppl 1:33-37
pubmed: 30225877
Obstet Gynecol. 2011 May;117(5):1105-1113
pubmed: 21508749
Rev Lat Am Enfermagem. 2020 Feb 14;28:e3232
pubmed: 32074205
Rev Saude Publica. 2019 Apr 01;53:28
pubmed: 30942270
Contraception. 2018 Sep;98(3):215-219
pubmed: 29750926
Cien Saude Colet. 2021 Aug 30;26(suppl 2):3493-3504
pubmed: 34468645
Cad Saude Publica. 2009;25 Suppl 2:S269-78
pubmed: 19684934
Cien Saude Colet. 2019 Mar;24(3):875-879
pubmed: 30892508
Int J Gynaecol Obstet. 2018 Sep;143 Suppl 1:38-42
pubmed: 30225875
J Pak Med Assoc. 2018 Apr;68(4):519-525
pubmed: 29808038
Rev Lat Am Enfermagem. 2002 May-Jun;10(3):446-7
pubmed: 12817400
Rev Esc Enferm USP. 2011 Mar;45(1):62-70
pubmed: 21445490
Lancet. 2012 Jul 14;380(9837):149-56
pubmed: 22784533
Cad Saude Publica. 2020 Oct 19;36(10):e00096919
pubmed: 33084831
Rev Gaucha Enferm. 2021 Feb 08;42:e20200015
pubmed: 33566948
Rev Esc Enferm USP. 2017 Dec 18;51:e03270
pubmed: 29267735
Eur J Contracept Reprod Health Care. 2017 Jun;22(3):222-226
pubmed: 28463028
Contraception. 2017 Jan;95(1):17-39
pubmed: 27771475
Aust N Z J Obstet Gynaecol. 2016 Feb;56(1):92-6
pubmed: 26662068
Rev Bras Ginecol Obstet. 2016 Mar;38(3):132-9
pubmed: 27022785

Auteurs

Thalita Vital Botelho (TV)

Universidade de São Paulo. São Paulo, São Paulo. Brazil.

Ana Luiza Vilela Borges (ALV)

Universidade de São Paulo. São Paulo, São Paulo. Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH